Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 9 | European Journal of Medical Research

Fig. 9

From: Inhibition of esophageal squamous cell carcinoma progression by MIR210HG and activation of the P53 signaling pathway to promote apoptosis and autophagy

Fig. 9

Overexpression of MIR210HG inhibits xenograft tumor growth. A–C Tumor volume size measurements were performed during subcutaneous inoculation of esophageal squamous carcinoma cells in nude mice for 18 days, and nude mice were necropsied after 18 days, and the tumors were exfoliated intact according to subgroups, weighed, and statistically counted; overexpression of MIR210HG significantly reduced the growth rate of the tumors as compared to the control group. D MIR210HG expression was detected by qRT-PCR in tumor specimens from mice in the Vector and OE-MIR210HG groups, respectively. E, F Immunohistochemical Ki67 staining was performed on tumor specimens from mice in the Vector and OE-MIR210HG groups, respectively, and scores were tallied. G, H Protein expression of P53, Bax, C-caspase3, Beclin- 1 and P62 in tumor specimens of mice in the Vector and OE-MIR210HG groups were further detected by Western blot, respectively, and statistically analyzed. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us